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Abstract
Background: Malaria is one of the leading causes of morbidity and mortality in children and HIV infection as well as
other factors may worsen the situation. This study was aimed at determining the factors influencing malaria parasite
prevalence and density as well as anaemia in HIV-infected children in Mutengene, Cameroon from November, 2012 to
April, 2013.
Methods: A semi-structured questionnaire was used to record information on socio-demographic factors and use of
preventive measures by caregivers of HIV-infected children aged 1–15 years and of both sexes. Venous blood was
collected; blood films were prepared and Giemsa-stained for parasite detection and speciation. Haemoglobin
concentration was measured and the anaemic status determined. Data was analysed using Epi Info 7 software.
Results: A total of 234 children were studied. The overall malaria parasite prevalence was 24.8 % (58) and was
significantly higher (31.9 %, P = 0 .004) in females, those who did not implement any preventive measure at all
(66.7 %, P = 0.03) and children who used antiretroviral therapy (ART) (28.6 %, P = 0.02) when compared with their
respective counterparts. Geometric mean parasite density (GMPD) was significantly higher (3098.4, P = 0.02) in
children who presented with fever, had CD4 T cells ≥500 cells/μL (491.3, P = 0.003) and those with moderate
anaemia (1658.8, P = 0.03) than their respective counterparts. Although there was no significant difference, GMPD
was however higher in males (549.0); those not on ART (635.0) and highest in children <5 years old (633.0) than
their respective counterparts. The overall prevalence of anaemia was 49.6 % (116). The value was significantly
highest (58.3 %, P = 0.01) in the 11–15 years age group; those with CD4 T cell level 200–499 (72.7 %, P = 0.001)
and children with fever (85.7 %, P = 0.01).
Conclusion: Implementation of proper and integrated malaria preventive measures as well as frequent monitoring of
anaemia on prescription of ART could likely improve the health conditions of HIV-infected children thus avoiding
malaria-related morbidity and mortality.
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Background
Malaria is a life threatening disease especially in children
whose immune systems are not yet fully developed. The
human immunodeficiency virus/acquired immunodefi-
ciency syndrome (HIV/AIDS) infection further worsens
the situation in children that are co-infected with both
diseases. Unfortunately, HIV/AIDS geographically over-
laps malaria infections in sub-Saharan Africa including
Cameroon [1]. Approximately two-thirds of the global
HIV/AIDS infected population lives in this area [2] and
in 2013 an estimated 210,000 of infected persons were
children [3]. More so, an estimated 163,000 malaria cases
have been reported in children in sub-Saharan Africa [4].
Both infections are known to negatively impact each other.
HIV-infected individuals are exposed to malaria infection
on a daily basis [5] and have a higher risk of recurrent
malaria episodes [6]. Malaria has also been associated with
increased HIV replication in co-infected individuals [7].
Children are generally susceptible and vulnerable to malaria
[8] and with HIV co-infection they may be at a higher risk
of severe malaria infection. Such a co-infection may also
retard the age-related acquisition of natural immunity to
malaria in children [6] and lead to higher parasite densities
thereby increasing the risk of anaemia [2, 5, 9, 10]. One of
the major outcomes of HIV infection is also anaemia. There
have been reports of high prevalence of childhood anaemia
in the Mount Cameroon area [11] and Mutengene is one of
the towns found in the area. Since malaria and HV/AIDS
remain health concerns in this area, there is a need for con-
stant monitoring of both diseases in all age groups.
Although there have been some reports on malaria in
HIV patients in Cameroon [12–16], none of them has
specifically focused on factors influencing the prevalence
of malaria and anaemia in HIV-infected children. Such
data remains very scanty in the country in general and
the South West Region in particular. Baseline data on
the prevalence of malaria and anaemia in this high risk
group of patients is of utmost importance as this will
help inform the design of interventions that can reduce
the burden of both diseases. Against this background,
this study was aimed at determining malaria parasite
prevalence, density and anaemia in HIV-infected chil-
dren attending the Care and Treatment Centre of the
Mutengene Baptist Hospital, Southwest Cameroon.
Methods
Study area
The study was carried out in the Care and Treatment
Centre of the Mutengene Baptist Hospital from November,
2012 to May, 2013. Mutengene is a semi-urban, road-
junction town, located in the Mount Cameroon area of the
South West Region, Cameroon. It is located at about
242 m above sea level, longitude 09° 18′ 29″ E and lati-
tudes 04° 05′57″ N. It has an equatorial climate made
up of a long rainy season that starts in mid-March and
ends in mid-November. The dry season spans from mid-
November to Mid-March. Weather records from the
Cameroon Development Corporation show a temperature
range, humidity and rainfall of 23 - 33 °C, 83.1 %
and >4000 mm respectively per annum. Malaria transmis-
sion in the town is perennial and the entomological inocu-
lation rate is reported as 36.76 bites/person/night [17].
Study design and population
A cross-sectional study was carried out on HIV-infected
children aged 1 to 15 years who came to the Care and
Treatment Centre of the Mutengene Baptist Hospital
(MBH). A total of 234 HIV-infected children from Muten-
gene and its environs in the outpatient department of MBH
were enrolled in the study between November, 2012 and
May, 2013. Before enrolment, a detailed explanation of the
study and its potential benefits (using an information sheet)
was given to parents/legal guardians of the children who
were then invited to participate in the study. All the chil-
dren who had been administered anti-malarials in the pre-
vious two weeks were excluded from the study.
A semi-structured questionnaire was administered to
each parent/guardian and interviews were done in English
and exceptionally in Pidgin English where necessary. The
questionnaire sought for information on the age, sex,
use of malaria preventive measures such as long lasting
insecticide-treated nets (LLIN), insecticide residual spraying
(IRS), presence/absence of stagnant water or bushes around
the home and screening of windows and doors with wire
mesh as well as use of and duration on ART. The questions
were all closed ended questions. Patients were classified
into different malaria prevention grades based on the num-
ber of mosquito preventive methods practised by the pa-
tient’s parent/guardian. They were classified into grades 0,
I, II, and III+ if a patient/care-giver applied none, one, two
or three and more preventive methods respectively.
Ethical considerations
An ethical clearance was obtained from the Cameroon
Baptist Convention (CBC) Institutional Review Board.
Informed consent forms were given to the parents/legal
guardians for reading and signature and an oral assent
was gotten from the children. Only those whose care-
givers accepted to allow them participate in the study by
signing the written informed consent forms and who ac-
cepted to participate voluntarily were included in the
study. All children below 1 year of age or those whose
parents refused to allow them take part in the study or
children who refused to participate in the study were ex-
cluded. All participants’ personal and health information
were handled only by members of the research team and
supporting health personnel. All patients’ data were held
in total respect of medical confidentiality. Following the
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test results, participants that were diagnosed with malaria,
severe anaemia and severe immunosuppression were im-
mediately notified and referred to the clinician of the
treatment centre for proper treatment and follow-up.
Collection of blood samples
Before blood collection, the axillary temperature of
each patient was measured. Fever was defined as
temperature ≥ 37.5 °C.Venous blood was collected into
well-labelled Ethylene Diamine Tetra Acetate (EDTA)
tubes, and thick and thin blood films were prepared
by the method of Cheesbrough [18] for the detection
and speciation of malaria parasites respectively.
Staining and microscopic examination of blood films
After fixing air-dried thin blood films with absolute metha-
nol, both thick and thin blood films were stained with 10 %
Giemsa for 30 min and examined under the ×100 (oil
immersion) objective of an Olympus® BX 40 F light micro-
scope (Olympus Optical Co. Ltd., Japan), for the detection
and identification of malaria parasites, respectively, using
the bench aids of Cheesbrough [18]. Slides were declared
negative if no asexual parasites or gametocytes were found
after examining 100 high-power fields. Slides were read by
two independent parasitologists, and in the case of any dis-
parity, they were read again by a third person. Malaria para-
sites were counted against 200 white blood cells (WBC) (or
500 WBCs in the case of very low parasitaemia) in thick
blood films, and parasite density was expressed as number
of parasites per microlitre (μL) of blood, assuming a WBC
count of 8,000 leucocytes per μL of blood [18].
Determination of haemoglobin concentration and
anaemia
A Urit12 haemoglobinometer was used for the determin-
ation of haemoglobin (Hb) value. The Hb strips were
placed on the haemoglobinometer and using a micropip-
ette, approximately 15–20 μL of blood was put on the hae-
moglobinometer and the haemoglobin value was read in
grams per decilitre (g/dL). Classification and severity of
anaemia was done according to Sumbele et al. [19].
Haemoglobin values less than 11 g/dL were considered
anaemic and anaemia severity was classified as follows:
Hb values between 10.0-10.9 g/dL, 7.0–9.9 g/dL and <
7.0 g/dL were considered as mild, moderate and severe
anaemia respectively.
Determination of CD4+ T-lymphocyte count
This was done using the CyFlow® Counter (Partec GmbH,
Münster, Germany). CD4 T-cell counts were categorised
according to WHO [20] as low or advanced stage (<200/μl),
moderate or chronic stage (200–499/μl) and high or asymp-
tomatic stage (≥500/μl). Clinical stages were classified ac-
cording to WHO criteria [20].
Statistical analysis
The data was entered into Microsoft excel 2007. Data
was analysed using Epi Info 7 software. Multiple logistic
regression analyses was performed, Chi Square or Fischer’s
exact tests were used to compare qualitative parameters.
ANOVA (F), Kruskal-Wallis (H) or Mann–Whitney (U)
tests were used to assess the differences between group
means. Odds Ratios (OR) were calculated to compare the
susceptibility of individuals or groups to different parame-
ters. Multivariate analysis was done using multinomial
logistic regression. Data was log transformed before the
calculation of geometric mean parasite density (GMPD)
was done for participants who were malaria-positive. Stat-
istical significance was set at P < 0.05.
Results
Baseline characteristics of the study population
A total of 234 out of 239 HIV-infected children aged
1–15 years participated in the study. Five (2.1 %) chil-
dren did not succumb to the blood collection proced-
ure (although their parents had consented) and were
therefore excluded from the study. The mean age of the
children was 7.2 ± 3.6 years, 61.5 % of them had CD4 T
cell counts ≥500 cells/μL of blood. There were more
females (59 %, n = 138) than males (41.0 %, n = 96). A
total of 182 (77.8 %) children were on ART while 52
(22.2 %) were not yet on ART. The overall malaria
parasite prevalence was 24.8 % (n = 58) while that of
anaemia was 49.6 % (n = 116).
Malaria parasite prevalence and density with respect to
age, sex, fever, CD4 T-cell counts and use of ART in the
study population
In the multivariate analysis, young age (5–10 years;
P = 0.031), sex (P = 0.007), clinical stage of the disease
(P = 0.0016) and use of ART (P = 0.0001) were independ-
ent risk factors significantly associated with malaria parasite
infection, as shown in Table 1. The highest malaria parasite
prevalence was recorded in children aged 5–10 years
(28.3 %) while the lowest was recorded in those aged
11–15 years (16.7 %). Although there was no significant
difference, the highest GMPD (parasites/μL of blood)
was recorded in children less than 5 years old (633.0
parasites/μL) and the lowest was recorded in those aged
5–10 years (234.0 parasites/μL).
In the bivariate model, malaria parasite prevalence was
associated with sex with females (χ2 = 8.185, OR = 2.74,
P = 0.004) being more likely to have malaria than males.
On the contrary, GMPD was higher in males (549.0 par-
asites/μL) than females (290.0 parasites/μL), but the dif-
ference was insignificant.
Malaria parasite prevalence though not significant was
higher (χ2 = 0.001, OR = 1.23, P = 0.99) in children pre-
senting with fever (28.6 %, n = 4) than those who did not
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have fever (24.5 %, n = 54). GMPD was significantly
higher (U = 34.00, P = 0.02) in children who presented
with fever (3098.4, 95 % CI: 72.0–133263.4 parasites/μL)
than in children who had no fever (287.3, 95 % CI: 61.3–
1346.6 parasites/μL).
Malaria parasite prevalence was highest in children
with CD4 T cell count <200 cells/μl (28.6 %, n = 8) and
lowest in those with CD4 T cell count ≥ 500 cells/μL
(25.0 %, n = 36), but there was no statistically significant
difference (χ2 = 0.208, P = 0.90) as indicated in Table 1.
The highest GMPD was recorded in those with CD4 T
cells ≥500 cells/μL (491.3, 95 % CI: 252.0–957.8 para-
sites/μL) while the lowest was in those with a CD4 T cell
count of <200 cells/μL (82.4, 95 % CI: 36.9–183.7 para-
sites/μL) and the difference was significant (H = 11.598,
P = 0.003) as shown in Table 1.
Children on ART were 3 times more likely to have mal-
aria parasites (χ2 = 5.414, OR = 3.07, P = 0.02) than those
who were not on ART. Table 1 shows that GMPD was
higher in children who were not on ART (635.0, 95 % CI:
37.2–10834.2 parasites/μL) than in those on therapy (314.8,
95 % CI: 189.3–523.5 parasites/μL) although the difference
was not significant (U = 136.0, P = 0.62).
The highest malaria parasite prevalence was recorded
in children at clinical stage 1 (36.4 %, n = 16) while the
lowest was recorded in those at clinical stage 4 (11.8 %,
n = 4) and the difference was significant (χ2 = 9.729, P =
0.02). The highest GMPD (512.2, 95 % CI: 231.3–1073.7
parasites/μL) was recorded in children at clinical stage 2
while the lowest (40, 95 % CI: 40–40 parasites/μL) was
recorded in children at clinical stage 4 (Table 1) and the
difference was significant (H = 14.36, P = 0.002).
Malaria parasite prevalence and density in relation to
preventive methods used by care givers of HIV-infected
children
Malaria parasite prevalence in children using LLINs
(22.9 %, n = 38) was lower than that in those not using
LLINs (29.4 %, n = 20), but the difference was not signifi-
cant (χ2 = 0.778, P = 0.38). GMPD was higher in those
who did not use LLINs (408.2, 95 % CI: 136.2–1223.3
parasites/μL) than in those who did (306.7, 95 % CI:





Bivariate analysis Multivariate analysis GMPD (range) Statistic P-value
OR (95 % CI) P-value$ OR (95 % CI) P-value£
Age Group (years)
< 5 66 16 (24.2) 1.67 (0.62–4.12) 0.455 1.02 (0.28–3.71) 0.976 633.0 (80–24000) H = 3.406 0.18
5–10 120 34 (28.3) 1.97 (0.84–4.67) 0.167 3.05 (1.11–8,42) 0.031* 234.0 (40–24000)
11–15 48 8 (16.7) Reference 463.3 (40–16000)
Sex
Males 96 14 (14.6) Reference 549.0 (40–2400) U = 218.0 0.10
Females 138 44 (31.9) 2.74 (1.40–5.36) 0.004* 3.08 (1.37–6.93) 0.007* 290.0 (40–24000)
Fever
Yes 14 4 (28.6) 1.23 (0.37–4.08) 0.985 1.38 (0.24–7.88) 0.716 3098.4 (400–24000) U = 34.00 0.02*
No 220 54 (24.5) Reference 287.3 (40–2400)
CD4 T cell (cells/μl of blood)
< 200 28 8 (28.6) 1.20 (0.49–2.96) 0.873 1.80 (0.55–5.85) 0.33 82.4 (40–360) H = 11.598 0.003*
200–499 44 12 (27.3) 1.07 (0.37–3.06) 0.881 1.20 (0.46–3.13) 0.70 405.2 (80–16000)
≥ 500 144 36 (25.0) Reference 491.3 (40–24000)
Clinical stages
Stage 1 44 16 (36.4) 4.29 (1.28–14.4) 0,027* 10.38 (2.43–44.46) 0.0016* 191.2 (40–5040) H = 14.36 0.002*
Stage 2 62 10 (16.1) 1.44 (0.42–5.00) 0.782 1.46 (0.36–5.87) 0.59 512.2 (40–5400)
Stage 3 82 24 (29.3) 3.10 (0.99–9.77) 0.077 2.62 (0.76–9.09) 0.13 498.4 (80–2400)
Stage 4 34 4 (11.8) Reference 40.0 (40–40)
Use of ART
Yes 182 52 (28.6) Reference 314.8 (40–24000) U = 136.00 0.62
No 52 6 (11.5) 3.07 (1.24–7.61) 0.019* 0.194 (0.06–0.62) 0.0001* 635.0 (40–16000)
OR Odds Ratio, *Statistically significant, CI Confidence Interval, $:Estimated by Yates adjusted Chi-Square, £:Estimated by Multiple Logistic Regression
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176.8–531.9 parasites/μL), but the difference was not
significant (H = 0.0271, P = 0.87).
Although malaria parasite prevalence was higher in chil-
dren who did not use IRS (25.6 %, n = 42), had bushes
(29.3 %, n = 34) or stagnant water (36.0 %, n = 18)
around their houses when compared with their respect-
ive counterparts the differences were however not sig-
nificant. When all the mosquito preventive methods
practised by care-givers of the participants were pulled
together, the highest rate of infection was recorded in
children whose care givers did not implement any mos-
quito preventive method at all, while the lowest was re-
corded in those whose care givers implemented at least
three or more of the mosquito preventive methods (the
use of bed nets, IRS, absence of stagnant water and bushes
around the home) as shown in Fig. 1 and there was a sig-
nificant difference between them (χ2 = 9.250, P = 0.03).
Prevalence and density of malaria parasites in relation to
anaemic status of HIV-infected children
The overall prevalence of anaemia in the study population
was 49.6 % (116). Generally, 34.5 % (/40/116) of the
anaemic cases were mild, 56.9 % (66/116) were moderate
and 8.6 % (10/116) were severe. Although there was no sta-
tistically significant difference, the prevalence of malaria
parasites was however higher in anaemia participants
(25.9 %, n = 30) than in the non-anaemic ones (23.7 %,
n = 28). The mean haemoglobin (±SD) concentration in
the mild, moderate, and severe categories were 10.7 ±
0.51 g/dL, 9.2 ± 0.93 g/dL, and 7.2 ± 0.67 g/dL respectively,
but there was no significant difference between them (χ2 =
5.321, P = 0.07). It was also observed that all the children
with severe anaemia were negative for malaria (0.0 %, 0).
GMPD was significantly higher (U = 58.0, P = 0.03) in those
who were moderately anaemic (1658.8, 95 % CI: 459.6–
5987.4 parasites/μL) when compared with their mildly
anaemic counterparts (232.9, 95 % CI: 84.1–644.8 para-
sites/μL) as indicated in Table 2.
Prevalence of anaemia in the study population with
respect to age, sex, fever, use of ART, CD4 T cell counts
and clinical staging
In multivariate analysis, young age (<5 years; P = 0.014),
fever (P = 0.012) and CD4 T cell count (200–499; P =
0.00017) were independent risk factors significantly asso-
ciated with anaemia. Children aged 11–15 years had the
highest prevalence of anaemia (58.3 %, n = 28) while
those aged <5 years had the lowest (33.5 %, n = 22); the
difference was statistically significant only with bivariate
analysis (P = 0.010) but not with the multivariate ana-
lysis. Anaemia was not associated with gender although
female children had a higher prevalence of anaemia
(53.6 %, n = 74) than the males (43.7 %, n = 42) (χ2 =
1.83, OR = 1.49, P = .18). Children who presented with
fever were 6.69 times more likely to be anaemic (χ2 =
6.319, OR = 6.69, P = .01) than those who had no fever.
Anaemia prevalence was significantly associated with the
level of CD4 T cell count (P = 0.001) with the highest value
recorded in children with 200–499 cells/μL (72.7 %, n = 32)
and the lowest in those with ≥500 cells/μL (38.9 %, n = 56)
as shown in Table 3. The prevalence of anaemia in children
who were not on ART (57.7 %, n = 30) was slightly higher
than in children who were on ART (47.3 %, n = 86) al-
though the difference was not significant. Even though the
WHO clinical staging was not significantly associated with
anaemic status in children, it was observed that those in
the clinical stage IV had the highest prevalence of anaemia
(58.8 %, n = 20) while the least was recorded in those who
were in clinical stage I of the HIV infection (40.9 %, n = 18).
Discussion
Malaria and HIV co-infection in children is a condition
of great public health significance as both infections
have devastating effects on the health of children espe-
cially those less than 5 years old. Both infections lead to
anaemia which can lead to serious consequences if not
treated on time. The overall malaria parasite prevalence
was 24.8 % in HIV-infected children. This value is simi-
lar to the 20.3 % malaria parasite prevalence reported in
Uganda in both HIV-exposed and unexposed children
[21]. The value is however less than that reported in
some studies carried out in apparently healthy school
children ≤15 years (33.8 % and 33.0 %) in the Mount
Cameroon region [22, 23]. This discrepancy may be at-
tributed to some state policies and strategies that have
recently been implemented to fight HIV/AIDS and mal-
aria in Cameroon. These include the free distribution of
ART to HIV/AIDS patients in the country as the main
control measure to improve their immune status and
slow down the deteriorating effect of the virus. The
number of care and treatment centres for HIV/AIDS
distributing ART has increased in the last decade. Anti-
malarial strategies include the free distribution of LLINS,
Fig. 1 Malaria parasite prevalence in the different prevention grades
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free treatment of malaria in children less than five
years old and increased access to artermisinin-based
combination therapies (ACTs) as well as malaria rapid
diagnostic tests at subsidized rates. These measures
have been relatively helpful especially in people living
in urban areas. Similar measures contributed to reduc-
tions in malaria-related morbidity and mortality in
HIV patients, particularly those living in urban settings
in Mozambique [24]. Despite the involvement of the
state and other development partners in the fight
against HIV/AIDS in Cameroon, the coverage rate of
antiretroviral treatment is still relatively low [25]. Un-
fortunately, malaria still remains a major cause of mor-
bidity and mortality in Cameroon, especially among
children and pregnant women, accounting for over
40 % hospital attendance [26].
Table 2 Malaria parasite prevalence and density with respect to status of anaemia and severity in the study population
Characteristic/category Number examined Number positive for malaria (%) OR (CI) GMPD (range)
Anaemic status
Non anaemic 118 28 (23.7) Reference 164.5 (40–960)
Anaemic 116 30 (25.9) 1.12 (0.62–2.03) 663.6 (40–24000)
Level of significance χ2 = 0.051, P =0.82 U = 288.0, P = 0.04*
Anaemia severity
Mild 40 14 (35.0) Reference 232.9 (40–5040)
Moderate 66 16 (24.2) 0.59 (0.25–1.40) 1658.8 (40–24000)
Severe 10 0 (0.0) — 0
Level of significance χ2 = 5.321, P = 0.07 U = 58.0, P = 0.03*
*Statistically significant, CI Confidence Interval, −– Statistic that could not be computed





Bivariate analysis Multivariate analysis
OR (95 % CI) p-value$ OR (95 % CI) p-value£
Age group (years)
< 5 66 22 (33.3) 0.36 (0.17–0.77) 0.014* 0.68 (0.25–1.87) 0.45
5–10 120 66 (55.0) 0.87 (0.44–1.72) 0.825 0.74 (0.34–1.62) 0.45
11–15 48 28 (58.3) Reference
Sex
Female 138 74 (53.6) 1.49 (0.88–2.51) 0.176 2.15 (1.11–4.15) 0.024*
Male 96 42 (43.7) Reference
Presence of fever
No 220 104 (47.3) Reference
Yes 14 12 (85.7) 6.69 (1.46–30.60) 0.012* 3.65 (0.69–19.20) 0.13
CD4 T Cell category (cells/μl)
< 200 28 16 (57.1) 2.10 (0.92–4.76) 0.114 1.99 (0.76–5.18) 0.16
200–499 44 32 (72.7) 4.19 (1.99–8.81) 0.00017* 3.79 (1.68–8.52) 0.0013*
≥ 500 144 56 (38.9) Reference
Clinical stages
Stage 1 44 18 (40.9) 0.48 (0.12–1.20) 0.180 0.73 (0.24–2.17) 0.57
Stage 2 62 34 (54.8) 0.85 (0.36–1.98) 0.87 0.97 (0.35–2.64) 0.95
Stage 3 82 36 (43.9) 0.55 (0.24–1.23) 0.21 0.45 (0.18–1.15) 0.09
Stage 4 34 20 (58.8) Reference
Use of ART
No 52 30 (57.7) 1.52 (0.82–2.84) 0.242 1.29 (0.60–1.29) 0.51
Yes 182 86 (47.3) Reference
OR Odds Ratio, CI Confidence Interval, $: Estimated by Yates adjusted Chi-Square, £: Estimated by Multiple Logistic Regression. *Statistically significant
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Malaria parasite prevalence in this study was higher in
children of younger age groups when compared with those
of the older age groups. In malaria endemic areas acquired
immunity to malaria is known to be both exposure- and
age-dependent. Hence, older children might have devel-
oped some degree of immunity as a result of repeated mal-
aria infections. This is in agreement with studies carried
out in the Mount Cameroon region [22].
The study showed that females were significantly more
infected with malaria parasites than males. This is in con-
trast with other studies [22, 27], which reported higher
malaria prevalence rates in males. This may be due to the
large proportion of females involved in this study. This
could also be due to the fact that HIV is more common in
females because of their biology and consequently leading
to a lower level of immunity in them.
Children on ART were more likely to be infected with
the malaria parasites than those who were not. This is in
contrast with other studies which showed that the preva-
lence of malaria parasites was lower in patients who were
on ART than in those who were not [28]. This discrepancy
may be due to lack of adherence to therapy by the patients.
Adherence to ART is a special issue in pediatrics because
many of the drugs are not child friendly [29]. Adherence is
important not only for individual patient responses to ART,
but also because lack of adherence to prescribed regimens
and sub-therapeutic levels of antiretroviral medications,
particularly protease inhibitors, may enhance development
of drug resistance and the likelihood of virologic failure. It
may also be related to the relatively small sample size
(22.2 %) of the patients who were not yet on ART in
the study population. However, these findings were
similar to one which showed that patients on ART had
a slightly higher malaria prevalence than those who
were not on ART [15]. On the other hand, GMPD was
comparable in patients who were on ART and those
who were not on ART. This finding is contrary to studies
of other authors who reported that certain ARVs such as
lopinavir/ritonavir can inhibit malaria parasite growth and
reduce the incidence of malaria [28, 30, 31]. Although it
was not investigated, it is worth noting that co-trimoxazole
is generally prescribed for prophylaxis against opportunistic
infections in HIV patients in treatment centres in
Cameroon and it is also known to have anti-malaria
properties [32].
When the vector control methods implemented by the
participants in the study were all pulled together, it was
observed that those who implemented at least three pre-
ventive methods had the least malaria prevalence, while
those who did not implement any vector control method
had the highest. This finding lends credence to the effi-
ciency of possible integrated vector control methods
against malaria infection. This needs to be encouraged
in HIV-infected individuals.
The prevalence of anaemia in children in the study
population was 49.6 %. This result was lower than values
reported by Sumbele et al. [11] and Ruhinda et al. [33].
This may be due to the wide scale use of anti-malaria
preventive measures that caused the decrease in the
prevalence of malaria infections in these children and
also the use of co-trimoxazole prescribed along with
ART which has been associated with reduced anaemia in
HIV infected children [34]. This confirms the fact that
malaria is one of the major contributing factors to an-
aemia in children [35]. That probably also explains why
GMPD was significantly higher in those who were an-
aemic as compared with their non-anaemic counterparts.
This study recorded a high prevalence of anaemia in
the HIV-infected children who had lower CD4 T cell
counts as well as those at clinical stage IV. This may be
due to chronic inflammation by the HIV infection or it
may be due to other opportunistic infections [36]. Sullivan
et al. [37] and Mocroft et al. [38] associated anaemia to
advancing HIV disease. The observed results could be due
to the increasing viral burden which could cause anaemia
through increased cytokine-mediated myelosuppression,
and/or a higher burden of comorbidities. The use of ART
in such patients usually leads to improvement in haemo-
globin and other related haematological indices, even
without specific additional treatment targeting anaemia
[30]. It could possibly be linked to the kind of ART that
the patients were taking as some of them have been re-
ported to cause anaemia. Kimbi et al. [15] also reported
high anaemia prevalence in patients who had CD4 T cells
less than 200 cells/μL of blood in Limbe, Cameroon.
Regardless of the mechanism, recognition of anaemia at
initiation of ART could be useful to alert clinicians with
regard to children requiring closer monitoring for possible
treatment failure. It is also possible that anaemic children
who did not respond adequately to ART might have been
harbouring some drug resistant strains of HIV. Anaemia
has been highlighted as an important independent prog-
nostic factor in HIV-infected individuals. It is also thought
to increase the risk of progression to AIDS and conse-
quently death in HIV infected patients [36]. The adverse
long term outcomes more likely reflect anaemia as a proxy
of more advanced disease.
The oldest children (11–15 years) had the highest
prevalence of anaemia while the youngest (<5 years) had
the lowest. This contrasts with other studies carried out
in southwest Cameroon [11, 22, 39] and Uganda [33].
Additionally, all children with severe anaemia were also
malaria parasite negative. This difference could be at-
tributed to the presence of the HIV infection and other
possible opportunistic infections. It is worth noting that
anaemia could have been caused by several factors includ-
ing haemoglobinopathies, poor nutritional status, bacter-
ial, viral and other parasitic infections like hookworm and
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Entamoeba histolytica. However, these were not investi-
gated in this study.
Our findings also revealed a high prevalence of anaemia
in children who presented with fever. This may be attrib-
uted to the high malaria prevalence and density observed in
patients who presented with fever. The main mechanism of
malaria anaemia pathogenesis involves the destruction of
both infected and uninfected red blood cells [40] thus lead-
ing to a reduction in haemoglobin values.
The study is the first of its kind in Mutengene,
Cameroon. Some limitations of this study include
firstly the lack of data on a comparable group of HIV
negative children in the same setting and this limits
our ability to interpret the prevalence results precisely.
A convenience sampling technique was used. This
sampling was biased and the sample may not be a repre-
sentative of the entire population. Self-reported informa-
tion on mosquito preventive methods by participants was
not verified and some of the information might have been
biased. We were not able to get any information on viral
loads as bouts of malaria are known to lead to higher viral
loads. We did not have information on the nutritional sta-
tus of the participants and this might have had an influ-
ence on anaemia in the patients. Our sample size was very
large in the dry season as compared to the rainy season
and this made seasonal comparison difficult.
Conclusion
Proper implementation of malaria preventive measures
and frequent monitoring of anaemia on prescription of
ART are likely to improve on the health conditions of
HIV-infected children thus reducing malaria-related
morbidity and mortality in this vulnerable population.
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